Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N1ST
|
|||
Former ID |
DIB007214
|
|||
Drug Name |
AFC-5128
|
|||
Synonyms |
AFC-5261; P2X7 purinoreceptor antagonists (neuropathic pain/ multiple sclerosis); P2X7 purinoreceptor antagonist (inflammatory disease/neurodegenerative disorder), Affectis; P2X7 purinoreceptor antagonists (neuropathic pain/ multiple sclerosis), Affectis
Click to Show/Hide
|
|||
Indication | Autoimmune diabetes [ICD-11: 5A10] | Investigative | [1] | |
Company |
Affectis Pharmaceuticals AG
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | P2X purinoceptor 7 (P2RX7) | Target Info | Antagonist | [1] |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Reactome | The NLRP3 inflammasome | |||
WikiPathways | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 484). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.